Commercial-Scale Synthesis of Protected 2′-Deoxycytidine and Cytidine Nucleosides
K. J. DIVAKAR, Chitra M. Sawant, Y. A. Mulla, Deepak V. Zemse, Sakina M. Sitabkhan, Bruce S. Ross, Yogesh S. Sanghvi
Abstract
K. J. DIVAKAR, Chitra M. Sawant, Y. A. Mulla, Deepak V. Zemse, Sakina M. Sitabkhan, Bruce S. Ross, Yogesh S. Sanghvi
Abstract
Transformation of 2'-deoxyuridine and uridine analogs to protected 2'-deoxycytidine and cytidine analogs has been investigated by two different methods. First, traditional triazolation protocol and second p-nitrophenoxylation method. Our studies conclude that the triazolation method is better and suitable for commercial scale-up.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Transformation of 2'-deoxyuridine and uridine analogs to protected 2'-deoxycytidine and cytidine analogs has been investigated by two different methods. First, traditional triazolation protocol and second p-nitrophenoxylation method. Our studies conclude that the triazolation method is better and suitable for commercial scale-up.
Key concepts: Cytidine, Deoxycytidine, Deoxyuridine, Uridine, Chemistry, Transformation (genetics), Combinatorial chemistry, Biology